Description
DIG
Digoxin (DIG) is a cardiac drug given to treat patients with congestive heart failure, angina and arrythmias. This drug must be monitored in patients to allow proper dose adjustment and prevent toxicity. Digoxin concentrations should be measured at least eight hours after an oral dose and ideally when concentrations have reached steady state.
Additional Information
Method: |
Enzyme Immunoassay, Chemiluminescence |
Principle: |
Competitive Assay, Streptavidin-Coated Plate |
Calibrators: |
0, 0.25, 0.5, 1, 2, 4 ng/ml |
Sample: |
25 µl |
Sensitivity: |
0.05 ng/ml |
Reading: |
RLU’s |
Total Time: |
30 Minutes |
Shelf Life: |
18 Months |